medigraphic.com
ISSN 1684-1824 (Electronic)

2019, Number 1

<< Back Next >>

Rev Méd Electrón 2019; 41 (1)

Epidemiological factors related to breast cancer. Hospital ¨José Ramón López Tabrane¨. Province of Matanzas. 2010-2015

García SJ, Busto HJ, Hernández MM, Schery GO, García BJA

Language: Spanish
References: 13
Page: 104-116
PDF size: 1178.71 Kb.


ABSTRACT

Introduction: breast cancer is the second cause of mortality in Cuban women, exceeded in the last three years only by tracheal, bronchial and lung neoplasms.
Objective: to describe several epidemiological characteristics related to this disease.
Material and method: a retrospective, observational-descriptive epidemiological study was carried out in women diagnosed with breast neoplasm in the Mastology consultation of the provincial hospital ¨Jose Ramon Lopez Tabrane¨, of Matanzas, in the period from January 1st 2010 to December 31st 2015. The sample was formed by 288 women, and for data analyses were used absolute frequencies and percents.
Results: there was a predominance of white patients (65.6 %), aged 40-69 years (71.2 %), and without familiar antecedents of breast cancer (86.1 %). The clinicalpathological variables were characterized by the predominance of stage II patients (62.2 %), with menopausal status at the moment they were diagnosed (56.9 %), and with a tumor sized 2-5 cm (77.4 %). The most frequent histological kind was the duct infiltrative carcinoma that was present in 85.7 % of the series; histological grade II tumor was diagnosed in 43.6 % of the patients. it is important to say that 61.1 % of the studied women showed gangliar affectation at the moment of the diagnosis.
Conclusions: the main socio-demographic and clinic-pathological factors related to this disease are described, allowing a closing to carry out future causal research.


REFERENCES

  1. Bray F, Ferlay J, Soerjomataram I, et al. A. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.2018;68(6):394-424. Citado en PubMed; PMID:30207593.

  2. Siegel R, Ma J, Zou Z, Jemal A. CA Cancer J Clin. 2014;64(1):9-29. Citado en PubMed; PMID: 24399786.

  3. Ministerio de Salud Pública. Anuario Estadístico 2017. Mortalidad por tumores malignos en el sexo femenino según localización y grupo de edad [Internet]. La Habana: Ministerio de Salud Pública; 2017 [citado 20/08/2017]. Disponible en: http://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Espa%C3%B1ol-2017-ed- 2018.pdf

  4. Álvarez C, Vich P, Brusint B, et al. Actualización del cáncer de mama en Atención Primaria (I/V). Semergen [Internet]. 2014 [citado 20/09/2017];40(8):460-72. Disponible en: http://www.elsevier.es/es-revista-medicina-familia-semergen-40-articuloactualizacion- del-cancer-mama-atencion-S113835931400104X

  5. Sanz N, Viñals A, Díaz P, et al. Graduación Histológica de Malignidad en el Carcinoma Ductal Infiltrante de la Mama. Hospital Universitario ¨V.I.Lenin¨. Correo Científico Médico de Holguín [Internet]. 2007 [citado 20/10/2017];11(1). Disponible en: https://www.researchgate.net/publication/326088459_Graduacion_Histologica_de_Mal ignidad_en_el_Carcinoma_Ductal_Infiltrante_SOE_de_la_Mama_Hospital_Universitario _VILenin

  6. Edge S, Byrd DR, Compton C, et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p. 347-76.

  7. Maffuz A, Labastida S, Sherwell S, et al. Supervivencia de pacientes con cáncer de mama. Análisis por factores pronóstico, clínicos y patológicos. Ginecol Obstet Mex[Internet]. 2016 [citado 20/10/2017];84(8):498-506. Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2016/gom168e.pdf

  8. Pelegrino R, Velázquez L, Pelegrino B, et al. Cáncer de mama en pacientes femeninas de Granma: 1992-2011. MULTIMED [Internet]. 2014 [citado 20/08/2017];18(2). Disponible en: http://www.revmultimed.sld.cu/index.php/mtm/article/view/38/0

  9. Aparicio LM, Hernández O, Toranzo D. Comportamiento clínico-epidemiológico del cáncer de mama en las pacientes del policlínico Guillermo Tejas Las Tunas. Rev Electrónica Dr. Zoilo E. Marinello Vidaurreta [Internet]. 2014 [citado 20/09/2018];39(5). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/277/463.

  10. Sherwell-S. Maffuz-A, López S, et al. Young age: The most significant factor contributing to poorer prognosis in Mexican women with breast cancer. J Cancer Biol Res [Internet]. 2015 [citado 20/09/2017];3(3):1066. Disponible en: https://www.jscimedcentral.com/CancerBiology/cancerbiology-3-1066.php

  11. De Freitas R, Disconzi R, Martins E, et al. Prognostic factors and overall survival of breast cancer in the city of Goiania, Brazil: a population-based study. Rev Col Bras Cir. 2017; 44(5): 435-43. Citado en PubMed; PMID: 29019571.

  12. Vázquez T, Krygier G, Barrios E, et al. Análisis de sobrevida de una población con cáncer de mama y su relación con factores pronósticos: estudio de 1.311 pacientes seguidas durante 230 meses. Rev Med Uruguay [Internet]. 2005 [citado 20/09/2018];21(2):107-21. Disponible en: http://www.rmu.org.uy/revista/21/2/2/es/3/resumen/

  13. Horta AB, Rojas I, Perdomo JC, et al. Estudio de agregación familiar de cáncer de mama en el municipio Matanzas. Familial aggregation study of breast cancer in Matanzas municipality. Rev Cubana Genet Comunit [Internet]. 2016 [citado 20/09/2017];10(3):39-45. Disponible en: http://bvs.sld.cu/revistas/rcgc/v10n3/050316.pdf




2020     |     www.medigraphic.com